Trademark: 79363055
Word
DMC
Status
Pending
Status Code
661
Status Date
Wednesday, April 3, 2024
Serial Number
79363055
Mark Type
3000
Filing Date
Tuesday, December 20, 2022

Trademark Owner History

Classifications
9 Downloadable computer software for data collection and management, automated calling, location tracking and sharing, and for providing information, clinical guidance and medical education and training featuring instruction in medicine for medical and health care purposes, for use in assisting with medical emergencies; downloadable application software for data collection and management, automated calling, location tracking and sharing, and for providing information, clinical guidance and medical education and training featuring instruction in medicine for medical and health care purposes, for use in assisting with medical emergencies; downloadable application software for use in medical emergencies, for providing clinical guidance, for providing medical information and for medical education and training purposes featuring instruction in medicine; downloadable application software for providing clinical guidance; downloadable application software providing medical information; downloadable application software for medical education and training purposes featuring instruction in medicine, emergency medicine and treatment of life threatening conditions; downloadable global positioning systems (GPS) software for tracking and mapping geospatial data; downloadable electronic publications in the nature of journals, information sheets, brochures, newsletters, and instruction manuals providing medical information; downloadable electronic publications in the nature of journals, information sheets, brochures, newsletters and instruction manuals in the field of medical education and training
5 Pharmaceutical preparations and substances in the field of emergency medicine for the treatment of anaphylactic reactions and cardiac conditions; pharmaceutical preparations and substances for the treatment of anaphylactic reactions; pharmaceutical preparations and substances for treatment of cardiac conditions; pharmaceutical preparations and substances for treatment of heart diseases; pharmaceutical preparations for the treatment of diabetes; glucose for medical purposes; glucose in the form of pharmaceutical products, namely glucose pharmaceutical preparation for medical purposes; glucose powder for medical purposes; inhalants, namely, inhalant pharmaceutical preparations for the treatment of anaphylactic reactions and cardiac conditions; drugs to be administered by inhalation, namely, inhalant pharmaceutical for the treatment of anaphylactic reactions and cardiac conditions; pharmaceutical preparations to be inhaled for the treatment of anaphylactic reactions and cardiac conditions
44 Medical services; emergency medical services; telemedicine services; emergency medical services regarding anaphylactic reactions and cardiac conditions; provision of medical information regarding emergency health care including in relation to anaphylactic reactions and cardiac conditions; health care medical consultancy services; provision of medical information; provision of medical information including regarding anaphylactic reactions and cardiac conditions
10 Medical apparatus for use in emergency treatment of life threatening conditions; medical devices for use in emergency treatment of life threatening conditions; inhalers for medical use, sold empty; medical inhalers sold empty and medical inhaler devices provided empty for administering pharmaceuticals; drug delivery apparatus and devices, namely, inhalers for the treatment of anaphylactic reactions and cardiac conditions, sold empty; medical apparatus, namely inhalers, for administering drugs into the lungs, sold empty; apparatus provided empty used for the inhalation of pharmaceutical preparations; filters for inhalers for medical purposes
42 Medical, clinical, scientific and technological research services and new product design relating thereto in the emergency medicine field; medical and scientific research, namely, conducting clinical trials for others; product design and development of medical emergency treatment solutions; design and development of medical devices; product development; scientific and medical research to develop new products; Software as a Service (SaaS) service featuring non-downloadable software for data collection and management, automated calling, location tracking and sharing, and for providing information, clinical guidance and medical education and training featuring instruction in medicine for medical and health care purposes, for use in assisting with medical emergencies; provision of online non-downloadable software for data collection and management, automated calling, location tracking and sharing, and for providing information, clinical guidance and medical education and training featuring instruction in medicine for medical and health care purposes, for use in assisting with medical emergencies; provision of online non-downloadable software for use in assisting with medical emergencies, for providing clinical guidance, for providing medical information, and for medical and education training purposes featuring instruction in medicine; provision of online non-downloadable software for providing clinical guidance; provision of online non-downloadable software providing medical information; provision of online non-downloadable software for medical education and training purposes featuring instruction in medicine; hosting an online website for the provision of medical information; hosting an online website for the provision of medical education and training services
The mark consists of a stylized incomplete heart design with an electrocardiogram line passing through the heart, with the stylized wording "DMC" on top of the right flat portion of the line.
DE MOTU CORDIS

Trademark Events
Apr 3, 2024
Teas/Email Correspondence Entered
Apr 2, 2024
Correspondence Received In Law Office
Apr 2, 2024
Teas Response To Office Action Received
Oct 25, 2023
Refusal Processed By Ib
Oct 4, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Oct 4, 2023
Refusal Processed By Mpu
Sep 23, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Sep 22, 2023
Non-Final Action Written
Sep 21, 2023
Assigned To Examiner
Feb 25, 2023
Application Filing Receipt Mailed
Feb 21, 2023
New Application Office Supplied Data Entered
Feb 16, 2023
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24